1. Home
  2. MNKD vs DSGR Comparison

MNKD vs DSGR Comparison

Compare MNKD & DSGR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MNKD
  • DSGR
  • Stock Information
  • Founded
  • MNKD 1991
  • DSGR 1952
  • Country
  • MNKD United States
  • DSGR United States
  • Employees
  • MNKD N/A
  • DSGR N/A
  • Industry
  • MNKD Biotechnology: Pharmaceutical Preparations
  • DSGR Industrial Machinery/Components
  • Sector
  • MNKD Health Care
  • DSGR Industrials
  • Exchange
  • MNKD Nasdaq
  • DSGR Nasdaq
  • Market Cap
  • MNKD 1.2B
  • DSGR 1.5B
  • IPO Year
  • MNKD 2004
  • DSGR N/A
  • Fundamental
  • Price
  • MNKD $5.54
  • DSGR $31.98
  • Analyst Decision
  • MNKD Buy
  • DSGR Buy
  • Analyst Count
  • MNKD 6
  • DSGR 1
  • Target Price
  • MNKD $10.33
  • DSGR $41.00
  • AVG Volume (30 Days)
  • MNKD 5.3M
  • DSGR 50.7K
  • Earning Date
  • MNKD 08-06-2025
  • DSGR 10-30-2025
  • Dividend Yield
  • MNKD N/A
  • DSGR N/A
  • EPS Growth
  • MNKD 149.32
  • DSGR N/A
  • EPS
  • MNKD 0.11
  • DSGR 0.08
  • Revenue
  • MNKD $301,736,000.00
  • DSGR $1,928,948,000.00
  • Revenue This Year
  • MNKD $14.52
  • DSGR $11.19
  • Revenue Next Year
  • MNKD $12.81
  • DSGR $4.44
  • P/E Ratio
  • MNKD $50.97
  • DSGR $345.76
  • Revenue Growth
  • MNKD 21.48
  • DSGR 13.48
  • 52 Week Low
  • MNKD $3.38
  • DSGR $21.87
  • 52 Week High
  • MNKD $7.63
  • DSGR $41.47
  • Technical
  • Relative Strength Index (RSI)
  • MNKD 72.22
  • DSGR 54.08
  • Support Level
  • MNKD $5.22
  • DSGR $30.64
  • Resistance Level
  • MNKD $6.20
  • DSGR $33.80
  • Average True Range (ATR)
  • MNKD 0.26
  • DSGR 0.80
  • MACD
  • MNKD 0.18
  • DSGR -0.22
  • Stochastic Oscillator
  • MNKD 73.17
  • DSGR 42.41

About MNKD MannKind Corporation

MannKind Corp is a biopharmaceutical company focused on the development and commercialization of inhaled therapeutic products for patients with diseases such as diabetes and pulmonary arterial hypertension. Its approved product, Afrezza (insulin human) Inhalation Powder, is an ultra-rapid-acting inhaled insulin used to improve glycemic control in adults with diabetes. The product consists of a dry powder formulation of human insulin delivered from a small portable inhaler.

About DSGR Distribution Solutions Group Inc.

Distribution Solutions Group Inc is an industrial distributor of maintenance and repair supplies. It has three operating segments namely Lawson, TestEquity, and Gexpro Services, of which key revenue is derived from the TestEquity segment. The TestEquity segment is a distributor of test and measurement equipment and solutions, electronic production supplies, and tool kits from its manufacturer partners supporting the technology, aerospace, defense, automotive, electronics, education and medical industries.

Share on Social Networks: